These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 16520400)

  • 1. Deoxycorticosterone acetate-salt rats: hypertension and sympathoexcitation driven by increased NaCl levels.
    O'Donaughy TL; Brooks VL
    Hypertension; 2006 Apr; 47(4):680-5. PubMed ID: 16520400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central action of increased osmolality to support blood pressure in deoxycorticosterone acetate-salt rats.
    O'Donaughy TL; Qi Y; Brooks VL
    Hypertension; 2006 Oct; 48(4):658-63. PubMed ID: 16966581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles of brain angiotensin II and C-type natriuretic peptide in deoxycorticosterone acetate-salt hypertension in rats.
    Nishimura M; Ohtsuka K; Sakamoto M; Nanbu A; Takahashi H; Yoshimura M
    J Hypertens; 1998 Aug; 16(8):1175-85. PubMed ID: 9794722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired cardiovascular reflexes precede deoxycorticosterone acetate-salt hypertension.
    Veelken R; Hilgers KF; Ditting T; Leonard M; Mann JF; Geiger H; Luft FC
    Hypertension; 1994 Nov; 24(5):564-70. PubMed ID: 7960014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mild DOCA-salt hypertension: sympathetic system and role of renal nerves.
    Kandlikar SS; Fink GD
    Am J Physiol Heart Circ Physiol; 2011 May; 300(5):H1781-7. PubMed ID: 21357502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of endothelin and vasopressin in DOCA-salt hypertension.
    Yu M; Gopalakrishnan V; McNeill JR
    Br J Pharmacol; 2001 Apr; 132(7):1447-54. PubMed ID: 11264238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic V2 vasopressin receptor stimulation increases basal blood pressure and exacerbates deoxycorticosterone acetate-salt hypertension.
    Fernandes S; Bruneval P; Hagege A; Heudes D; Ghostine S; Bouby N
    Endocrinology; 2002 Jul; 143(7):2759-66. PubMed ID: 12072411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood pressure-lowering effect of an orally active vasopressin V1 receptor antagonist in mineralocorticoid hypertension in the rat.
    Burrell LM; Phillips PA; Stephenson JM; Risvanis J; Rolls KA; Johnston CI
    Hypertension; 1994 Jun; 23(6 Pt 1):737-43. PubMed ID: 8206571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extrarenal Na+ balance, volume, and blood pressure homeostasis in intact and ovariectomized deoxycorticosterone-acetate salt rats.
    Titze J; Luft FC; Bauer K; Dietsch P; Lang R; Veelken R; Wagner H; Eckardt KU; Hilgers KF
    Hypertension; 2006 Jun; 47(6):1101-7. PubMed ID: 16636196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resting Afferent Renal Nerve Discharge and Renal Inflammation: Elucidating the Role of Afferent and Efferent Renal Nerves in Deoxycorticosterone Acetate Salt Hypertension.
    Banek CT; Knuepfer MM; Foss JD; Fiege JK; Asirvatham-Jeyaraj N; Van Helden D; Shimizu Y; Osborn JW
    Hypertension; 2016 Dec; 68(6):1415-1423. PubMed ID: 27698066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain endogenous angiotensin II receptor type 2 (AT2-R) protects against DOCA/salt-induced hypertension in female rats.
    Dai SY; Peng W; Zhang YP; Li JD; Shen Y; Sun XF
    J Neuroinflammation; 2015 Mar; 12():47. PubMed ID: 25885968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Splanchnic sympathetic nerves in the development of mild DOCA-salt hypertension.
    Kandlikar SS; Fink GD
    Am J Physiol Heart Circ Physiol; 2011 Nov; 301(5):H1965-73. PubMed ID: 21890693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of a methionine-supplemented diet on the blood pressure of Sprague-Dawley and deoxycorticosterone acetate-salt hypertensive rats.
    Robin S; Maupoil V; Laurant P; Jacqueson A; Berthelot A
    Br J Nutr; 2004 Jun; 91(6):857-65. PubMed ID: 15182389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is functional upregulation of the 5-HT2B receptor in deoxycorticosterone acetate salt-treated rats blood pressure dependent?
    Watts SW; Harris B
    Gen Pharmacol; 1999 Dec; 33(6):439-47. PubMed ID: 10647769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperresponsiveness of monoaminergic mechanisms in DOCA/NaCl hypertensive rats.
    Chen YF; Nagahama S; Winternitz SR; Oparil S
    Am J Physiol; 1985 Jul; 249(1 Pt 2):H71-9. PubMed ID: 4014487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time course of synergistic interaction between DOCA and salt on blood pressure: roles of vasopressin and hepatic osmoreceptors.
    Brooks VL; Freeman KL; Qi Y
    Am J Physiol Regul Integr Comp Physiol; 2006 Dec; 291(6):R1825-34. PubMed ID: 16857894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac sympathetic hyperinnervation in deoxycorticosterone acetate-salt hypertensive rats.
    Lee TM; Chen CC; Chang NC
    Clin Sci (Lond); 2012 Oct; 123(7):445-57. PubMed ID: 22507072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of vasopressin antagonism on structure and mechanics of small arteries and vascular expression of endothelin-1 in deoxycorticosterone acetate salt hypertensive rats.
    Intengan HD; He G; Schiffrin EL
    Hypertension; 1998 Oct; 32(4):770-7. PubMed ID: 9774378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-Hydroxytryptamine lowers blood pressure in normotensive and hypertensive rats.
    Diaz J; Ni W; Thompson J; King A; Fink GD; Watts SW
    J Pharmacol Exp Ther; 2008 Jun; 325(3):1031-8. PubMed ID: 18305011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic central potassium infusion prevents deoxycorticosterone-salt hypertension in rats.
    Klarr SA; Keep RF; Betz AL
    Am J Physiol; 1995 Feb; 268(2 Pt 2):H646-52. PubMed ID: 7864190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.